OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eczematous Drug Eruptions
Amy E. Blum, Susan Burgin
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 3, pp. 349-366
Closed Access | Times Cited: 18

Showing 18 citing articles:

Differential diagnosis of contact dermatitis: A practical‐approach review by the EADV Task Force on contact dermatitis
David Pesqué, Olivier Aerts, Mojca Bizjak, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 9, pp. 1704-1722
Open Access | Times Cited: 12

Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role?
Matteo Megna, Giuseppina Caiazzo, Melania Parisi, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 5, pp. 918-925
Closed Access | Times Cited: 24

Atopic Dermatitis in Adults: Focus on Topical Therapy
Leisa L. Marshall
The Senior Care Pharmacist (2025) Vol. 40, Iss. 3, pp. 123-134
Closed Access

Head and neck dermatitis: a variant of atopic dermatitis
Leszek Blicharz, Agnieszka Michalczyk, Małgorzata Maj, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 160, Iss. 2
Closed Access

Atopic dermatitis in skin of colour. Part 2: considerations in clinical presentation and treatment options
Christian Gan, Satveer K. Mahil, Andrew Pink, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 10, pp. 1091-1101
Open Access | Times Cited: 6

Treatment of paradoxical eczematous eruption in psoriasis treated with secukinumab: A case report
Yu Xiao, Shanshan Peng, Xiangjun Li, et al.
Medicine (2023) Vol. 102, Iss. 6, pp. e32844-e32844
Open Access | Times Cited: 5

Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience
Michela Starace, Luca Rapparini, Stephano Cedirian, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 3
Closed Access

Identifying a Case of an Atenolol-induced Papulosquamous Eruption
Daniel A. Fischer, Joseph Gofman, Graham Litchman, et al.
SKIN The Journal of Cutaneous Medicine (2024) Vol. 8, Iss. 3, pp. 1537-1541
Open Access

Asteatotic eczema following paclitaxel and carboplatin chemotherapy for lung carcinoma
Tejas Vishwanath, Sunanda Mahajan, Prachi Gole, et al.
Indian Journal of Dermatology Venereology and Leprology (2024), pp. 1-3
Open Access

Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments
Yanzhen Pang, William Q. Nguyen, Liliana Guerrero, et al.
American Journal of Clinical Dermatology (2024)
Closed Access

Eczematous Drug Eruptions: Identification and Management of Pharmacological Culprits in Primary Care
Joseph Gofman, Darcy Tocci, Daniel L. Fischer, et al.
Dermatological Reviews (2024) Vol. 5, Iss. 6
Closed Access

Eczematous drug eruptions mostly manageable with emollients and corticosteroids
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2021) Vol. 38, Iss. 1, pp. 13-18
Closed Access | Times Cited: 1

Eczematous eruption associated with two beta‐3 adrenergic agonists for overactive bladder
Madison Meyer, Hailey Olds, Kayla St. Claire, et al.
International Journal of Dermatology (2023) Vol. 62, Iss. 10
Closed Access

Approach to red, scaly eruptions in the older patient
Ankit Gupta, Sara Lee de Menezes
Australian Journal of General Practice (2023) Vol. 52, Iss. 12, pp. 856-860
Open Access

Exanthematous Drug Eruption to Intravenous Iron: A Case Report
Shilpa S. Mantri, Niraj Ballam Nagaraj, Chirag Patel, et al.
Cureus (2022)
Open Access

Pompholyx as a side effect of intravenous immunoglobulin (IVIg)
Claire Doyle, Karen Eustace
BMJ Case Reports (2022) Vol. 15, Iss. 3, pp. e248772-e248772
Open Access

Author reply to: Comment on: ‘Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?’
Angelo Ruggiero, Matteo Megna, Giuseppina Caiazzo, et al.
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 396-397
Closed Access

Pompholyx as a Side Effect of Intravenous Immunoglobulin (IVIg)
Claire Doyle
Clinical Dermatology Open Access Journal (2021) Vol. 6, Iss. 4
Open Access

Page 1

Scroll to top